Cargando…
Exercise testing in late-onset glycogen storage disease type II patients undergoing enzyme replacement therapy
Enzyme replacement therapy (ERT) has recently became available for patients with glycogen storage disease type II. Previous studies have demonstrated clinical efficacy of enzyme replacement therapy, however, data on physiological variables related to exercise tolerance are scarce. Four glycogen stor...
Autores principales: | Marzorati, Mauro, Porcelli, Simone, Bellistri, Giuseppe, Morandi, Lucia, Grassi, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527663/ https://www.ncbi.nlm.nih.gov/pubmed/23182645 http://dx.doi.org/10.1016/j.nmd.2012.10.017 |
Ejemplares similares
-
Metabolic Myopathies: “Human Knockout” Models and Translational Medicine
por: Grassi, Bruno, et al.
Publicado: (2020) -
Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study
por: Sechi, Annalisa, et al.
Publicado: (2020) -
S2.1 Enzyme replacement therapy (ERT)
in Glycogen Storage Disease Type II:
the first treatment developed
por: Angelini, Corrado, et al.
Publicado: (2011) -
Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014) -
Evaluation of muscle biopsy in late-onset GSDII patients before and after enzyme replacement therapy (ERT)
por: Violano, R, et al.
Publicado: (2013)